Early diagnosis of invasive aspergillosis in neutropenic patients with bi-weekly serial screening of circulating galactomannan by Platelia® Aspergillus;Diagnóstico precoz de la aspergilosis invasora en enfermos neutropénicos mediante la detección bisemanal de galactomanano en suero con Platelia® Aspergillus

Revista Iberoamericana de Micologia

Volumn 20, Issue 3, 2003, Pages 99-102

  Pazos, Carmen ^a   Del Palacio, Amalia ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Galactomannan; Invasive aspergillosis; Neutropenic patients

Indexed keywords

GALACTOMANNAN;

ADULT; ARTICLE; ASPERGILLOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HIGH RISK POPULATION; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; NEUTROPENIA; NON INVASIVE MEASUREMENT; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ADULT; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; FUNGEMIA; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MANNANS; MIDDLE AGED; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

ASPERGILLUS;

EID: 0347762500     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices and outcomes. Medicine 2000; 79: 250-260.
2. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-803.
3. Groll AH, Shah PM, Mentzel C, et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23-32.
4. Vogesen M, Wanders A, Haas A, Ruckdeschel G. A four-year review of fatal aspergiliosis. Eur J Clin Microbiol Infect Dis 1999; 18: 42-45.
5. Von Eiff M, Zuhlsdorf M, Roos N, et al. Pulmonary fungal infections in patients with hematological malignancies-diagnostic approaches. Ann Hematol 1995; 70: 135-141.
6. Denning DW. Invasive aspergillosis in immunocompromised patients. Cur Opinion Infect Dis 1994; 7: 456-462.
7. Denning DW. Early diagnosis of invasive aspergillosis. Lancet 2000; 355: 423-424.
8. Prentice HG, Kibbler CC, Prentice AG. Towards a targeted, risk-based, antifungal strategy in neutropenic patients. Br J Haematol 2000; 110: 273-284.
9. Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999; 37: 3223-3228.
10. Maertens J, Verhaegen J, Lagrou K, et al. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-1610.
11. Sulahian A, Boutboul F, Ribaud P, et al. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001: 91: 311-318.
12. Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patient. J Clin Oncol 2002; 20: 1898-1906.
13. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an internacional consensus. Clin Infect Dis 2002; 34: 7-14.
14. Swanink CM, Meis JF, Rijs AJ, et al. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997; 35: 257-260.
15. Boutboul F, Alberti C, Leblanc T, et al. Invasive aspergillosis in allogenic stem cell transplant recipients: increasing anti-genemia is associated with progressive disease. Clin Infect Dis 2002; 34: 939-943.